Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 249-262

  Lotan, Dafna ^a   Benhar, Itai ^a   Alvarez, Kathy ^b   Mascaro Blanco, Adita ^b   Brimberg, Lior ^a,c   Frenkel, Dan ^a   Cunningham, Madeleine W ^b   Joel, Daphna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Animal model; Dopamine; Pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS); Serotonin; Streptococcus group A (GAS); Sydenham's chorea (SC)

Indexed keywords

ANTIBODY; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; IMMUNOGLOBULIN G; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; STREPTOCOCCUS ANTIBODY; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; STREPTOCOCCAL ANTIBODY; SEROTONIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROOMING; GROUP A STREPTOCOCCAL INFECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INFUSION; MALE; MOTOR PERFORMANCE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; WALKING; WESTERN BLOTTING; ANIMAL TISSUE; BEHAVIOR DISORDER; INCLINED BEAM WALKING TEST; MARBLE BURYING TEST; MOTOR DYSFUNCTION; PATHOGENESIS; STREPTOCOCCUS PYOGENES; ANIMAL; IMMUNOLOGY; LEWIS RAT; METABOLISM; MOTOR ACTIVITY;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; IMMUNOGLOBULIN G; MALE; MOTOR ACTIVITY; RATS; RATS, INBRED LEW; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; STREPTOCOCCUS PYOGENES;

EID: 84898540917     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.02.009     Document Type: Article

References (72)

1. Albelda N., Joel D. Current animal models of obsessive compulsive disorder: an update. Neuroscience 2012, 211:83-106.
2. Archelos J.J., Hartung H.P. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000, 23:317-327.
3. Ayalon L., Doron R., Weiner I., Joel D. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus. Exp. Neurol. 2004, 186:46-58.
4. Baragli A., Alturaihi H., Watt H.L., Abdallah A., Kumar U. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 - co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell. Signal. 2007, 19:2304-2316.
5. Barsottini O.G., Ferraz H.B., Seviliano M.M., Barbieri A. Brain SPECT imaging in Sydenham's chorea. Braz. J. Med. Biol. Res. 2002, 35:431-436.
6. Ben-Pazi H., Sadan O., Offen D. Striatal microinjection of Sydenham chorea antibodies: using a rat model to examine the dopamine hypothesis. J. Mol. Neurosci. 2012, 46:162-166.
7. Bonthius D.J., Karacay B. Sydenham's chorea: not gone and not forgotten. Semin. Pediatr. Neurol. 2003, 10:11-19.
8. Brimberg L., Benhar I., Mascaro-Blanco A., Alvarez K., Lotan D., Winter C., Klein J., Moses A.E., Somnier F.E., Leckman J.F., Swedo S.E., Cunningham M.W., Joel D. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012, 37:2076-2087.
9. Bronze M.S., Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 1993, 151:2820-2828.
10. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19:3248-3257.
11. Church A.J., Cardoso F., Dale R.C., Lees A.J., Thompson E.J., Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002, 59:227-231.
12. Citak E.C., Gucuyener K., Karabacak N.I., Serdaroglu A., Okuyaz C., Aydin K. Functional brain imaging in Sydenham's chorea and streptococcal tic disorders. J. Child Neurol. 2004, 19:387-390.
13. Coplan J.D., Tamir H., Calaprice D., DeJesus M., de la Nuez M., Pine D., Papp L.A., Klein D.F., Gorman J.M. Plasma anti-serotonin and serotonin anti-idiotypic antibodies are elevated in panic disorder. Neuropsychopharmacology 1999, 20:386-391.
14. Cox C.J., Sharma M., Leckman J.F., Zuccolo J., Zuccolo A., Kovoor A., Swedo S.E., Cunningham M.W. Brain human monoclonal autoantibody from Sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease. J. Immunol. 2013, 191:5524-5541.
15. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 2000, 13:470-511.
16. Cunningham M.W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol. 2012, 24:408-416.
17. Dale R.C. Post-streptococcal autoimmune disorders of the central nervous system. Dev. Med. Child Neurol. 2005, 47:785-791.
18. Dale R.C., Merheb V., Pillai S., Wang D., Cantrill L., Murphy T.K., Ben-Pazi H., Varadkar S., Aumann T.D., Horne M.K., Church A.J., Fath T., Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012, 135:3453-3468.
19. Demiroren K., Yavuz H., Cam L., Oran B., Karaaslan S., Demiroren S. Sydenham's chorea: a clinical follow-up of 65 patients. J. Child Neurol. 2007, 22:550-554.
20. Denys D., van der Wee N., Janssen J., De Geus F., Westenberg H.G. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol. Psychiatry 2004, 55:1041-1045.
21. Dilenge M.E., Shevell M.I., Dinh L. Restricted unilateral Sydenham's chorea: reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning. J. Child Neurol. 1999, 14:509-513.
22. Doyle F., Cardoso F., Lopes L., Mendes M., Dias F., Cruz L., Tavares R., Camargos A., Carneiro M., Dias-Lopes C., Chavez-Olortegui C. Infusion of Sydenham's chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity. Neurosci. Lett. 2012, 523:186-189.
23. Flaisher-Grinberg S., Klavir O., Joel D. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 2008, 11:811-825.
24. Gabbay V., Coffey B. Obsessive-compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges. J. Child Adolesc. Psychopharmacol. 2003, 13:209-212.
25. Garvey M.A., Snider L.A., Leitman S.F., Werden R., Swedo S.E. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J. Child Neurol. 2005, 20:424-429.
26. Gause C., Morris C., Vernekar S., Pardo-Villamizar C., Grados M.A., Singer H.S. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J. Neuroimmunol. 2009, 214:118-124.
27. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry 2000, 157:281-283.
28. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33:23-34.
29. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J. Neuroimmunol. 2000, 111:195-202.
30. Hesse S., Muller U., Lincke T., Barthel H., Villmann T., Angermeyer M.C., Sabri O., Stengler-Wenzke K. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res. 2005, 140:63-72.
31. Hesse S., Stengler K., Regenthal R., Patt M., Becker G.A., Franke A., Knupfer H., Meyer P.M., Luthardt J., Jahn I., Lobsien D., Heinke W., Brust P., Hegerl U., Sabri O. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 2011, 14:606-617.
32. Hoffman K.L., Hornig M., Yaddanapudi K., Jabado O., Lipkin W.I. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J. Neurosci. 2004, 24:1780-1791.
33. Husby G., van de Rijn I., Zabriskie J.B., Abdin Z.H., Williams R.C. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J. Exp. Med. 1976, 144:1094-1110.
34. Huyser C., Veltman D.J., de Haan E., Boer F. Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging. Neurosci. Biobehav. Rev. 2009, 33:818-830.
35. Jahanshahi A., Vlamings R., van Roon-Mom W.M., Faull R.L., Waldvogel H.J., Janssen M.L., Yakkioui Y., Zeef D.H., Kocabicak E., Steinbusch H.W., Temel Y. Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington's disease. Neuroscience 2013, 238:71-81.
36. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993, 92:39-43.
37. Kingston D., Glynn L.E. A cross-reaction between Str. pyogenes and human fibroblasts, endothelial cells and astrocytes. Immunology 1971, 21:1003-1016.
38. Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 2003, 9:914-920.
39. Kirvan C.A., Swedo S.E., Snider L.A., Cunningham M.W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J. Neuroimmunol. 2006, 179:173-179.
40. Kolb B., Holmes C. Neonatal motor cortex lesions in the rat: absence of sparing of motor behaviors and impaired spatial learning concurrent with abnormal cerebral morphogenesis. Behav. Neurosci. 1983, 97:697-709.
41. Kotby A.A., El Badawy N., El Sokkary S., Moawad H., El Shawarby M. Antineuronal antibodies in rheumatic chorea. Clin. Diagn. Lab. Immunol. 1998, 5:836-839.
42. Linthicum D.S., Munoz J.J., Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 1982, 73:299-310.
43. Loiselle C.R., Lee O., Moran T.H., Singer H.S. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov. Disord. 2004, 19:390-396.
44. Maes M., Ringel K., Kubera M., Anderson G., Morris G., Galecki P., Geffard M. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. J. Affect. Disord. 2013, 150(2):223-230.
45. Marques-Dias M.J., Mercadante M.T., Tucker D., Lombroso P. Sydenham's chorea. Psychiatr. Clin. North Am. 1997, 20:809-820.
46. Martino D., Chiarotti F., Buttiglione M., Cardona F., Creti R., Nardocci N., Orefici G., Veneselli E., Rizzo R. The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev. Med. Child Neurol. 2011, 53:951-957.
47. Michel P.P., Toulorge D., Guerreiro S., Hirsch E.C. Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease. FASEB J. 2013, 27(9):3414-3423.
48. Moretti G., Pasquini M., Mandarelli G., Tarsitani L., Biondi M. What every psychiatrist should know about PANDAS: a review. Clin. Pract. Epidemiol. Ment. Health 2008, 4:13.
49. Murphy T.K., Kurlan R., Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J. Child Adolesc. Psychopharmacol. 2010, 20:317-331.
50. Nikolaus S., Antke C., Beu M., Muller H.W. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders-results from in vivo imaging studies. Rev. Neurosci. 2010, 21:119-139.
51. Olver J.S., O'Keefe G., Jones G.R., Burrows G.D., Tochon-Danguy H.J., Ackermann U., Scott A., Norman T.R. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. J. Affect. Disord. 2009, 114:321-326.
52. Pavone P., Bianchini R., Parano E., Incorpora G., Rizzo R., Mazzone L., Trifiletti R.R. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr. Neurol. 2004, 30:107-110.
53. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
54. Perani D., Garibotto V., Gorini A., Moresco R.M., Henin M., Panzacchi A., Matarrese M., Carpinelli A., Bellodi L., Fazio F. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 2008, 42:306-314.
55. Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999, 354:1153-1158.
56. Peterson B.S., Leckman J.F., Tucker D., Scahill L., Staib L., Zhang H., King R., Cohen D.J., Gore J.C., Lombroso P. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch. Gen. Psychiatry 2000, 57:364-372.
57. Reeves S., Mehta M., Howard R., Grasby P., Brown R. The dopaminergic basis of cognitive and motor performance in Alzheimer's disease. Neurobiol. Dis. 2010, 37:477-482.
58. Renart J., Reiser J., Stark G.R. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera - method for studying antibody specificity and antigen structure. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:3116-3120.
59. Reynolds J.A., Tanford C. Binding of dodecyl sulfate to proteins at high binding ratios - possible implications for state of proteins in biological membranes. Proc. Natl. Acad. Sci. U. S. A. 1970, 66. 1002-&.
60. Schott K., Schaefer J.E., Richartz E., Batra A., Eusterschulte B., Klein R., Berg P.A., Bartels M., Mann K., Buchkremer G. Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res. 2003, 121:51-57.
61. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., Kiessling L.S. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998, 50:1618-1624.
62. Singer H.S., Mink J.W., Loiselle C.R., Burke K.A., Ruchkina I., Morshed S., Parveen S., Leckman J.F., Hallett J.J., Lombroso P.J. Microinfusion of antineuronal antibodies into rodent striatum: failure to differentiate between elevated and low titers. J. Neuroimmunol. 2005, 163:8-14.
63. Swedo S.E., Grant P.J. Annotation: PANDAS: a model for human autoimmune disease. J. Child Psychol. Psychiatry 2005, 46:227-234.
64. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 1998, 155:264-271.
65. Swedo S.E., Leonard H.L., Kiessling L.S. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994, 93:323-326.
66. Swedo S.E., Leonard H.L., Schapiro M.B., Casey B.J., Mannheim G.B., Lenane M.C., Rettew D.C. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993, 91:706-713.
67. Tanaka S., Matsunaga H., Kimura M., Tatsumi K., Hidaka Y., Takano T., Uema T., Takeda M., Amino N. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J. Neuroimmunol. 2003, 141:155-164.
68. Taranta A., Stollerman G.H. The relationship of Sydenham's chorea to infection with group A streptococci. Am. J. Med. 1956, 20:170-175.
69. Taylor J.R., Morshed S.A., Parveen S., Mercadante M.T., Scahill L., Peterson B.S., King R.A., Leckman J.F., Lombroso P.J. An animal model of Tourette's syndrome. Am. J. Psychiatry 2002, 159:657-660.
70. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets - procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:4350-4354.
71. Urakawa S., Hida H., Masuda T., Misumi S., Kim T.S., Nishino H. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats. Neuroscience 2007, 144:920-933.
72. Yaddanapudi K., Hornig M., Serge R., De Miranda J., Baghban A., Villar G., Lipkin W.I. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry 2010, 15:712-726.